AskGene Pharma Inc.
9Patents
9Active
9Granted
44Portfolio score
Filing activity: Sep 17, 2015 → Nov 21, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10077308B2 | PD-L1 specific monoclonal antibodies for disease treatment and diagnosis | Chemistry; Metallurgy | 4 | Active |
| US11059885B2 | Angiopoietin 2, VEGF dual antagonists | Chemistry; Metallurgy | 3 | Active |
| US10654922B2 | Angiopoietin 2, VEGF dual antagonists | Chemistry; Metallurgy | 3 | Active |
| US10287336B2 | Feline erythropoietin receptor agonists | Chemistry; Metallurgy | 2 | Active |
| US11746147B2 | Angiopoietin 2, VEGF dual antagonists | Chemistry; Metallurgy | 1 | Active |
| US11505618B2 | Antibodies and methods for making and using the same | Chemistry; Metallurgy | 1 | Active |
| US12312413B2 | Antibodies and methods for making and using the same | Chemistry; Metallurgy | 0 | Active |
| US12043662B2 | Angiopoietin 2, VEGF dual antagonists | Chemistry; Metallurgy | 0 | Active |
| US11845801B2 | IL-15 prodrugs and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.